The accident at the Fukushima Daiichi site presented a unique challenge in fulfilling this mandate. Following the accident, the IAEA established a new approach and developed innovative technologies to ...

SINGAPORE - Media OutReach Newswire - 10 June 2025 – Capgemini, and Dai-ichi Life Holdings, today announced the signing of a multi-year agreement to establish a Global Capability Center (GCC) in India ...

AstraZeneca and partner Daiichi Sankyo have their first phase 3 data for TROP2-targeting antibody-drug conjugate (ADC) datopotamab deruxtecan (Dato-DXd) – in lung cancer – in one of the most ...

Dai-ichi Life Holdings has revealed plans to acquire a 15% stake in UK-based insurer M&G through on-market purchases “to capture long-term value creation opportunities across an array of ...

In a bold move toward a more sustainable future, Daiichi Properties has partnered with Shell Energy Philippines to power its office buildings with renewable energy. The agreement, which took ...

These data, along with other updates across our industry-leading oncology portfolio, underscore our commitment to pushing the boundaries of science to create new medicines or combination ...

Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...

(MRK) and Daiichi Sankyo Company, Limited (DSKYF) has been withdrawn, the companies said in a statement on Thursday. The decision followed topline overall survival (OS) data from the confirmatory ...

(RGA) entered agreement with The Dai-ichi Life Insurance Company, under which an RGA subsidiary will reinsure ¥150 billion of statutory reserves from Dai-ichi Life.

May 29, 2025 Merck, Daiichi pull US application for 'guided missile' therapy for lung cancer Merck and Japan-based Daiichi Sankyo have withdrawn their U.S. application for an experimental lung ...